It’s a matter of public record that if HHS Secretary Robert F. Kennedy had his way, he’d ban direct-to-consumer pharma ...

The first patient has already been treated with bemdaneprocel, a one-shot treatment designed to replace the ...

Accurate labelling is equally important in blood transfusion services. Effectively tracking blood as it moves from donation ...

In this post-BIO virtual interview, editor-in-chief Jonah Comstock speaks with Iya Khalil, VP and head of data, AI, and ...

Metsera went public earlier this year, raising $275 million for its obesity pipeline against a backdrop of a fairly ...

Stealth BioTherapeutics has claimed FDA approval for Forzinity, the first treatment for ultra-rare disease Barth syndrome, ...

The FDA has cleared the new version for across most of the solid tumour indications already granted for Keytruda, which is ...

As President Donald Trump started his state visit to the UK, GSK unveiled a massive $30 billion investment in manufacturing ...

Panellists voted by 8 to 3 – with one abstention – to change the CDC recommendations to state that MMRV is not recommended ...

The American Academy of Paediatrics (AAP) recommended in August that all infants and toddlers aged six to 23 months receive ...

Having already voted unanimously that all pregnant women should be tested for hepatitis B as a precursor to deciding an HBV ...

There is only one approved drug for ultra-rare disease fibrodysplasia ossificans progressiva (FOP) on the US market, but ...